Company

Apogee Therapeutics

As of the edition of 20 October 2026, Apogee Therapeutics runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Status not established1
Total2

Where its trials are

  • Immune system: 4 trials led
  • Inherited and neonatal: 3 trials led
  • Skin and connective tissue: 3 trials led